INTRODUCTION
In the context of epidemics and pandemics, in November 2019, an outbreak of respiratory disease caused by the new coronavirus (SARS-CoV-2), was detected in the city of Wuhan, China [1]. In March 2020, the new coronavirus (COVID-19) spread throughout the world causing respiratory disease and deaths especially in risk groups such as the elderly pregnant women, immunocompromised people, and others [1].
The World Health Organization (WHO) declared, on January 30, 2020, that the disease outbreak caused by COVID-19 constitutes a Public Health The emergency of International Importance - the highest level of alert in the Organization, as provided for in the Regulations International Health. On March 11, 2020, COVID-19 has characterized by WHO as a pandemic [2].
About 6,287,771 cases of COVID-19 (93,246 new about the previous day) and 379,941 deaths (3,621 new concerning the previous day) were confirmed worldwide by June 3, 2020 [3]. In the Region of the Americas, 1,036,155 people who were infected with the new coronavirus recovered, according to data from June 3, 2020. The Pan American Health Organization (PAHO) and WHO is providing technical support to Brazil and other countries, in the preparation and response to the COVID-19 outbreak [4,5].
In Brazil, on January 22, 2020, the Public Health Emergency Operations Center for COVID-19 was activated, a strategy provided for in the National Public Health Emergency Response Plan of the Ministry of Health (MS). Thus, the Ministry of Health established a structured document based on existing actions for notification, registration, investigation, management, and adoption of preventive measures, in analogy to the accumulated knowledge about SARS-CoV-2 and the Influenza Treatment Protocol: 2017 of the MS [6].
The recommendations are also guided by the Covid-19 Expert Consensus for Clinical Management, held on March 10 and 11, 2020, at the headquarters of the Pan American Health Organization / World Health Organization (PAHO / WHO ) in Brasilia, when national and international experts were gathered for discussion and deepening on the subject [8-10].
In this context, Severe Acute Respiratory Syndrome (SARS) (Severe Acute Respiratory Syndrome - SARS) is a severe acute respiratory disease caused by SARS-CoV. SARS is much more drastic than other coronavirus infections [11]. SARS is an influenza-like illness that occasionally causes severe progressive respiratory failure. SARS-CoV was first detected in Guangdong, China, in November 2002 and subsequently spread to more than 30 countries [12]. SARS-CoV is transmitted from person to person by close personal contact. It believed to transmitted more readily by respiratory droplets produced when an infected person coughs or sneezes. The diagnosis of SARS is clinical, and treatment is supportive [13].
Therefore, this study presented through a systematic review the considerations about the actions for notification, registration, investigation, management, and adoption of preventive measures on SARS-CoV-2 in Severe Acute Respiratory Syndrome (SARS).